Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$47.5M |
| 2 |
Johnson & Johnson
JNJ
|
+$34.9M |
| 3 |
Phillips 66
PSX
|
+$34.7M |
| 4 |
Chevron
CVX
|
+$31.9M |
| 5 |
Johnson Controls International
JCI
|
+$31.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COUP
Coupa Software Incorporated
COUP
|
+$51.8M |
| 2 |
COWN
Cowen Inc. Class A Common Stock
COWN
|
+$49.5M |
| 3 |
EVOP
EVO Payments, Inc. Class A Common Stock
EVOP
|
+$48.2M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$37.7M |
| 5 |
STOR
STORE Capital Corporation
STOR
|
+$23.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.69% |
| 2 | Industrials | 11.81% |
| 3 | Healthcare | 11.19% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Ionis Pharmaceuticals
IONS
$10B
| $2.59M | 0.04% |
72,577
+36,212
| +100% | +$1.36M |
|
652
ProFrac Holding
ACDC
$854M
| $2.59M | 0.04% |
204,677
+468
| +0.2% | +$9.1K |
|
653
Coca-Cola
KO
$396B
| $2.59M | 0.04% |
+41,772
| New | +$2.53M |
|
654
Tecnoglass Holdings
TGLS
$1.83B
| $2.59M | 0.04% |
+61,695
| New | +$2.21M |
|
655
L3Harris
LHX
$49.1B
| $2.58M | 0.04% |
13,171
+10,178
| +340% | +$2.08M |
|
656
CALL
lululemon athletica
LULU
$13.8B
| $2.58M | 0.04% |
7,100
+100
| +1% | +$31.4K |
|
|
DISH
657
DELISTED
DISH Network Corp.
DISH
| $2.58M | 0.04% |
+276,545
| New | +$3.49M |
|
658
PUT
Applied Materials
AMAT
$382B
| $2.58M | 0.04% |
21,000
+4,500
| +27% | +$517K |
|
659
Match Group
MTCH
$9.33B
| $2.56M | 0.04% |
66,681
+45,532
| +215% | +$1.99M |
|
660
State Street Financial Select Sector SPDR ETF
XLF
$56.3B
| $2.53M | 0.04% |
78,802
+33,747
| +75% | +$1.17M |
|
|
FNA
661
DELISTED
Paragon 28, Inc.
FNA
| $2.53M | 0.04% |
148,269
+124,670
| +528% | +$2.22M |
|
662
PUT
NextEra Energy
NEE
$175B
| $2.53M | 0.04% |
+32,800
| New | +$2.52M |
|
663
Regeneron Pharmaceuticals
REGN
$85.5B
| $2.52M | 0.04% |
3,072
-542
| -15% | -$409K |
|
664
PepsiCo
PEP
$198B
| $2.52M | 0.04% |
13,840
-62,683
| -82% | -$11M |
|
665
CALL
Microchip Technology
MCHP
$40.7B
| $2.52M | 0.04% |
30,100
-5,400
| -15% | -$431K |
|
666
iShares MSCI Switzerland ETF
EWL
$2.45B
| $2.52M | 0.04% |
55,627
+26,082
| +88% | +$1.15M |
|
667
CALL
Parker-Hannifin
PH
$127B
| $2.52M | 0.04% |
+7,500
| New | +$2.48M |
|
668
PUT
ON Semiconductor
ON
$28.4B
| $2.52M | 0.04% |
30,600
+6,200
| +25% | +$471K |
|
669
PUT
KLA
KLAC
$234B
| $2.52M | 0.04% |
63,000
-8,000
| -11% | -$315K |
|
670
NorthWestern Energy
NWE
$4.29B
| $2.52M | 0.04% |
43,461
+7,259
| +20% | +$414K |
|
|
671
CALL
Johnson & Johnson
JNJ
$651B
| $2.51M | 0.04% |
16,200
+12,500
| +338% | +$2.02M |
|
672
CALL
Nike
NKE
$61B
| $2.5M | 0.04% |
20,400
+9,900
| +94% | +$1.22M |
|
673
PUT
Dominion Energy
D
$58.8B
| $2.5M | 0.04% |
44,700
+7,700
| +21% | +$451K |
|
674
The GEO Group
GEO
$4.32B
| $2.47M | 0.04% |
313,455
+4,689
| +2% | +$46K |
|
|
RXDX
675
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $2.47M | 0.04% |
22,989
+2,386
| +12% | +$275K |
|
Similar funds
Paul Tudor Jones's Q1 2023 Portfolio in Review
As of Q1 2023, Paul Tudor Jones held 3,136 positions worth $6.46B, up 28% from $5.06B the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.
Paul Tudor Jones deployed $1.28B of net new capital in Q1 2023, opening 836 new positions and adding to 737 existing holdings. Its largest new stake was Johnson & Johnson: 216,183 shares worth $33.5M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $37.7M trimmed.
- Paul Tudor Jones's largest Q1 2023 buy was Johnson & Johnson: 216,183 shares worth $33.5M.
- Paul Tudor Jones added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $47.5M increase.
- Paul Tudor Jones's biggest Q1 2023 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $37.7M.
- Paul Tudor Jones fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $51.8M.
- Paul Tudor Jones's ten largest holdings make up 6.8% of its $6.46B portfolio in Q1 2023.
- Paul Tudor Jones opened 836 new positions and closed 800 in Q1 2023.
- Paul Tudor Jones's portfolio value rose 28% quarter-over-quarter to $6.46B.
Based on Tudor Investment Corp's 13F filing for Q1 2023, filed 15 May 2023.